GlaxoSmithKline Pharmaceuticals Overview
- Status
- Public
- Employees
- 4,364
- Stock Symbol
- 500660
- Investments
- 2
- Share Price
- $20.40
- (As of Monday Closing)
GlaxoSmithKline Pharmaceuticals General Information
Description
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
- Mumbai
- India
GlaxoSmithKline Pharmaceuticals Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $20.40 | $20.81 | $13.88 - $24.51 | $3.46B | 169M | 3.29K | -$0.27 |
GlaxoSmithKline Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 3,598,766 | 2,665,745 | 2,972,013 | 2,698,465 |
| Revenue | 418,266 | 453,815 | 446,922 | 445,384 |
| EBITDA | (18,140) | 44,836 | 93,515 | 81,516 |
| Net Income | (45,566) | 13,118 | 63,634 | 54,400 |
| Total Assets | 369,576 | 415,744 | 563,190 | 606,333 |
| Total Debt | 5,937 | 5,548 | 84 | 152 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
GlaxoSmithKline Pharmaceuticals Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0. 00000000 | Self | Board Member | 000 0000 |
| 00000 000000000 | Self | Independent and Non-Executive Director | 000 0000 |
GlaxoSmithKline Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGlaxoSmithKline Pharmaceuticals Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 16-Jul-2015 | 00000 00000 00 | 00000 | Biotechnology | |
| Silarus Therapeutics | 22-Sep-2014 | Early Stage VC | 0000 | Drug Discovery |